190 related articles for article (PubMed ID: 9058774)
1. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.
Zhang GX; Yu LY; Shi FD; Xiao BG; Björk J; Hedlund G; Link H
J Neuroimmunol; 1997 Mar; 73(1-2):175-82. PubMed ID: 9058774
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
[TBL] [Abstract][Full Text] [Related]
3. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H
Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
[TBL] [Abstract][Full Text] [Related]
4. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
Zhang GX; Xiao BG; Yu LY; van der Meide PH; Link H
J Neuroimmunol; 2001 Feb; 113(1):10-8. PubMed ID: 11137572
[TBL] [Abstract][Full Text] [Related]
6. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
[TBL] [Abstract][Full Text] [Related]
7. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
Ma CG; Zhang GX; Xiao BG; Link H
Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
[TBL] [Abstract][Full Text] [Related]
8. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
[TBL] [Abstract][Full Text] [Related]
9. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
[TBL] [Abstract][Full Text] [Related]
11. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
[TBL] [Abstract][Full Text] [Related]
12. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis.
Li H; Shi FD; Bai X; Huang Y; Diab A; He B; Link H
J Neurol Sci; 1998 Nov; 161(1):40-6. PubMed ID: 9879680
[TBL] [Abstract][Full Text] [Related]
14. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Qiao J; Olsson T; Huang WX
J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
[TBL] [Abstract][Full Text] [Related]
15. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
[TBL] [Abstract][Full Text] [Related]
16. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor.
Ma CG; Zhang GX; Xiao BG; Link J; Olsson T; Link H
J Neuroimmunol; 1995 Apr; 58(1):51-60. PubMed ID: 7537280
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
Wang ZY; He B; Qiao J; Link H
J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
[TBL] [Abstract][Full Text] [Related]
20. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.
Bakhiet M; Yu LY; Ozenci V; Khan A; Shi FD
Clin Exp Immunol; 2006 May; 144(2):290-8. PubMed ID: 16634803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
